urinary retention
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Cervical cancer stage Ib1-IIa2 (2009 FIGO cervical cancer clinical staging) patients of 20-60 years old who have urinary retention after the catheter is removed 14-60 days after radical hysterectomy, whose residual urine is more than 100ml measured for two consecutive days. 2. The operation record confirmed that the operation method was radical hysterectomy; 3. Patients whoes expected survival time is more than 12 months; 4. Patients who agree to participate in this trial and have signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who have received pelvic radiotherapy in the past; 2. Patients older than 60 years old or younger than 20 years old; 3. Patients who undergo radical hysterectomy which have not been confirmed by surgery and pathology; 4. Patients with previous symptoms such as urinary dysfunction, urinary incontinence, or abnormal preoperative urodynamic tests; 5. Patients with severe urinary tract infection or vesicovaginal fistula; 6. Patients who are in the acute stage of other diseases: impaired consciousness, body temperature greater than 38°C, unstable vital signs or acute abdomen, etc.; 7. Patients who have important organ function impairment: liver enzymes> 2 times the upper limit of normal, creatinine> 2 times the upper limit of normal, blood amylase> 2 times the upper limit of normal, heart function grade 3-4, etc.; 8. Patients who have brain disease or abnormal judgment ability; 9. Patients who have drug and/or alcohol abuse; 10. Patients with mental illness receiving medication; 11. Patients who participated in other clinical trials within 4 weeks before the start of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| urodynamic measurement;urine routine;residual urine; | — |
Countries
China
Contacts
Obstetrics & Gynecology Hospital of Fudan University